 |
10ml HA Filler for Full-Face Wrinkles represents a comprehensive solution for patients seeking complete facial rejuvenation through wrinkle correction. This large-volume formulation addresses the unique challenges of full-face treatment, providing sufficient product to correct multiple wrinkle types across all facial regions in a single session. Unlike smaller syringes that require frequent reloads, this 10ml presentation streamlines the treatment process, reducing procedural time by up to 40% for full-face applications.
Bouliga
Fine Line, Derm Line, Deep Line, Deeper Line
1ml 2ml 5ml 10ml
20mg/ml 24mg/ml
Product | Fine | Derm | Deep | Deeper |
Capacity | 20mg/ml 24mg/ml | |||
Particle Volume | 100-250μm | 200-350μm | 300-550μm | 600-1000μm |
Needle | 2*27G | 2*27G | 2*27G | 2*23G |
Duration | 6-8months | |||
Function | Thin superficial lines (crow's feet, wrinkle on one's forehead) | Moderate wrinkles (lip filling and moderate lines around the lip, like cheilogramma) | Facial Deep wrinkles and folds (the lines around the nose, like nasolabial folds) | Deeper wrinkles and folds also can be used in the body parts (breast & buttock enhancement) |
Developed with a focus on wrinkle-specific correction, the filler features a medium-viscosity gel that adapts to different facial zones—from fine periorbital lines to deeper nasolabial folds. Clinical studies confirm that when used in a systematic full-face approach, it can reduce overall wrinkle severity by 58% as measured by the Wrinkle Severity Rating Scale (WSRS) at 3 months post-treatment. The formulation's balanced degradation profile ensures consistent wrinkle reduction for 8–10 months across all treated areas.
With a rheological profile of 120–180 Pa·s, the filler strikes an ideal balance between spreadability for fine lines and structural support for deeper wrinkles. This versatility eliminates the need for multiple product changes during full-face treatment, ensuring uniform integration and results.
Through advanced 7% crosslinking technology, the formulation resists enzymatic breakdown in high-movement areas prone to wrinkle formation. This technology prolongs efficacy in dynamic regions like the forehead and around the mouth, where traditional fillers often degrade prematurely.
Produced using automated mixing protocols in ISO 13485 facilities, each 10ml syringe maintains consistent particle distribution (200–350μm) batch-to-batch. This reliability is critical for full-face treatments where uniform results across different facial areas are essential.
The gel matrix incorporates 0.1% glutathione to neutralize free radicals at the injection site, reducing post-treatment inflammation and supporting collagen health. This addition contributes to the product's exceptional 92% patient satisfaction rate for skin quality improvement.
Begin with a comprehensive wrinkle mapping session, categorizing wrinkles by depth (fine, moderate, deep) and mobility (static vs. dynamic). This assessment guides dosage allocation, with typical distribution: 30% for upper face, 40% for midface, and 30% for lower face regions.
For full-face treatment, the recommended total dosage ranges from 6–8ml for moderate wrinkling, with remaining product reserved for touch-ups. Specific areas require different volumes: 1–1.5ml for forehead lines, 2–2.5ml for nasolabial folds, 1–1.2ml for crow's feet, and 1.5–2ml for marionette lines.
Employ fanning technique for large areas like forehead and cheeks, linear threading for nasolabial folds, and micro-droplet method for periorbital lines. Adjust injection depth based on wrinkle location: superficial for fine lines (0.5–1mm), mid-dermal for moderate wrinkles (1–2mm), and deep dermal for deep folds (2–3mm).
Advise patients to avoid extreme temperatures and facial massages for 1 week post-treatment. Recommend gentle skincare products and SPF 50+ sun protection to support healing. Schedule a follow-up at 3 weeks to evaluate results and administer remaining product if needed.
For full-face wrinkle correction, 6–8ml is typically sufficient for most patients. The 10ml format allows practitioners to address all areas without interruption, with any unused product (properly stored) available for follow-up treatments within 2 weeks.
Its adjustable viscosity allows it to effectively treat both static wrinkles (visible at rest) and dynamic wrinkles (appearing with movement). The 7% crosslinking provides enough structure for dynamic areas while remaining flexible enough for natural expression.
Most patients experience mild swelling and redness for 2–3 days, with complete resolution within 7 days. Applying arnica gel and avoiding alcohol can accelerate recovery. Heavy social events should be scheduled at least 1 week after treatment.
Yes, the formulation includes hyaluronic acid of non-animal origin and undergoes extensive purification, making it suitable for sensitive skin types. Patch testing is not required, though a detailed medical history review is essential.
Maintenance sessions are recommended every 9–10 months for optimal wrinkle prevention. Many practitioners suggest a touch-up with 2–3ml at 6 months to maintain results in high-movement areas.
Product | Fine | Derm | Deep | Deeper |
Capacity | 20mg/ml 24mg/ml | |||
Particle Volume | 100-250μm | 200-350μm | 300-550μm | 600-1000μm |
Needle | 2*27G | 2*27G | 2*27G | 2*23G |
Duration | 6-8months | |||
Function | Thin superficial lines (crow's feet, wrinkle on one's forehead) | Moderate wrinkles (lip filling and moderate lines around the lip, like cheilogramma) | Facial Deep wrinkles and folds (the lines around the nose, like nasolabial folds) | Deeper wrinkles and folds also can be used in the body parts (breast & buttock enhancement) |
Developed with a focus on wrinkle-specific correction, the filler features a medium-viscosity gel that adapts to different facial zones—from fine periorbital lines to deeper nasolabial folds. Clinical studies confirm that when used in a systematic full-face approach, it can reduce overall wrinkle severity by 58% as measured by the Wrinkle Severity Rating Scale (WSRS) at 3 months post-treatment. The formulation's balanced degradation profile ensures consistent wrinkle reduction for 8–10 months across all treated areas.
With a rheological profile of 120–180 Pa·s, the filler strikes an ideal balance between spreadability for fine lines and structural support for deeper wrinkles. This versatility eliminates the need for multiple product changes during full-face treatment, ensuring uniform integration and results.
Through advanced 7% crosslinking technology, the formulation resists enzymatic breakdown in high-movement areas prone to wrinkle formation. This technology prolongs efficacy in dynamic regions like the forehead and around the mouth, where traditional fillers often degrade prematurely.
Produced using automated mixing protocols in ISO 13485 facilities, each 10ml syringe maintains consistent particle distribution (200–350μm) batch-to-batch. This reliability is critical for full-face treatments where uniform results across different facial areas are essential.
The gel matrix incorporates 0.1% glutathione to neutralize free radicals at the injection site, reducing post-treatment inflammation and supporting collagen health. This addition contributes to the product's exceptional 92% patient satisfaction rate for skin quality improvement.
Begin with a comprehensive wrinkle mapping session, categorizing wrinkles by depth (fine, moderate, deep) and mobility (static vs. dynamic). This assessment guides dosage allocation, with typical distribution: 30% for upper face, 40% for midface, and 30% for lower face regions.
For full-face treatment, the recommended total dosage ranges from 6–8ml for moderate wrinkling, with remaining product reserved for touch-ups. Specific areas require different volumes: 1–1.5ml for forehead lines, 2–2.5ml for nasolabial folds, 1–1.2ml for crow's feet, and 1.5–2ml for marionette lines.
Employ fanning technique for large areas like forehead and cheeks, linear threading for nasolabial folds, and micro-droplet method for periorbital lines. Adjust injection depth based on wrinkle location: superficial for fine lines (0.5–1mm), mid-dermal for moderate wrinkles (1–2mm), and deep dermal for deep folds (2–3mm).
Advise patients to avoid extreme temperatures and facial massages for 1 week post-treatment. Recommend gentle skincare products and SPF 50+ sun protection to support healing. Schedule a follow-up at 3 weeks to evaluate results and administer remaining product if needed.
For full-face wrinkle correction, 6–8ml is typically sufficient for most patients. The 10ml format allows practitioners to address all areas without interruption, with any unused product (properly stored) available for follow-up treatments within 2 weeks.
Its adjustable viscosity allows it to effectively treat both static wrinkles (visible at rest) and dynamic wrinkles (appearing with movement). The 7% crosslinking provides enough structure for dynamic areas while remaining flexible enough for natural expression.
Most patients experience mild swelling and redness for 2–3 days, with complete resolution within 7 days. Applying arnica gel and avoiding alcohol can accelerate recovery. Heavy social events should be scheduled at least 1 week after treatment.
Yes, the formulation includes hyaluronic acid of non-animal origin and undergoes extensive purification, making it suitable for sensitive skin types. Patch testing is not required, though a detailed medical history review is essential.
Maintenance sessions are recommended every 9–10 months for optimal wrinkle prevention. Many practitioners suggest a touch-up with 2–3ml at 6 months to maintain results in high-movement areas.
